Vaxcyte (PCVX) Interest Expenses (2019 - 2022)

Vaxcyte (PCVX) has 4 years of Interest Expenses data on file, last reported at $2000.0 in Q2 2022.

• Interest Expenses for Q2 2022 came in at $2000.0, down 71.43% year-over-year; the trailing twelve-month figure through Mar 2023 was $2000.0 (down 71.43% YoY), and the FY2022 annual result was $2000.0, down 71.43% from the prior year.
• Interest Expenses slipped to $2000.0 in Q2 2022 per PCVX's latest filing, from $7000.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $11000.0 in Q2 2019 and troughed at $2000.0 in Q2 2022.
• A 4-year average of $7166.7 and a median of $7000.0 in 2019 frame the typical range for Interest Expenses.
• On a YoY basis, Interest Expenses climbed as much as 71.43% in 2022 and fell as far as 71.43% in 2022.
• A 4-year view of Interest Expenses shows it stood at $7000.0 in 2019, then changed by 0.0% to $7000.0 in 2020, then changed by 0.0% to $7000.0 in 2021, then plunged by 71.43% to $2000.0 in 2022.
• Business Quant data shows PCVX's Interest Expenses at $2000.0 in Q2 2022, $7000.0 in Q2 2021, and $7000.0 in Q1 2020.